BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neri I, Virdi A, Corsini I, Guglielmo A, Lazzarotto T, Gabrielli L, Misciali C, Patrizi A, Lanari M. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown. J Eur Acad Dermatol Venereol 2020;34:2630-5. [PMID: 32533899 DOI: 10.1111/jdv.16751] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Fennell J, Onel K. Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment. Front Pediatr 2022;10:904616. [DOI: 10.3389/fped.2022.904616] [Reference Citation Analysis]
2 Rubio-Tomás T, Skouroliakou M, Ntountaniotis D. Lockdown Due to COVID-19 and Its Consequences on Diet, Physical Activity, Lifestyle, and Other Aspects of Daily Life Worldwide: A Narrative Review. Int J Environ Res Public Health 2022;19:6832. [PMID: 35682411 DOI: 10.3390/ijerph19116832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 De Greef A, Coulie PG, Baeck M. Pandemic chilblains: Are they SARS-CoV-2-related or not? Clin Immunol 2022;237:108984. [PMID: 35338000 DOI: 10.1016/j.clim.2022.108984] [Reference Citation Analysis]
4 Teh N, Pennington V, Martin LK. 'Home-school toes' - a case series of paediatric perniosis presentations. Australas J Dermatol 2022. [PMID: 35316542 DOI: 10.1111/ajd.13827] [Reference Citation Analysis]
5 Dinulos JE, Dinulos JG. Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. Curr Opin Pediatr 2021;33:691-703. [PMID: 34670262 DOI: 10.1097/MOP.0000000000001076] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Neale H, Hawryluk EB. COVID-19 Pediatric Dermatology. Dermatol Clin 2021;39:505-19. [PMID: 34556241 DOI: 10.1016/j.det.2021.05.012] [Reference Citation Analysis]
7 Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, Docampo-Simón A, Belinchón-Romero I, Ramos-Rincón JM. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2022;36:24-38. [PMID: 34545625 DOI: 10.1111/jdv.17672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li H, Zhao Y, Zhou L. Cutaneous manifestations in children with SARS-CoV-2 infection and/or COVID-19: what do we know after 10 months under this pandemic? Int J Dermatol 2021. [PMID: 34530491 DOI: 10.1111/ijd.15882] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Kolivras A, Thompson C, Pastushenko I, Mathieu M, Bruderer P, de Vicq M, Feoli F, Harag S, Meiers I, Olemans C, Sass U, Dehavay F, Fakih A, Lam-Hoai XL, Marneffe A, Van De Borne L, Vandersleyen V, Richert B. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. J Cutan Pathol 2021. [PMID: 34272741 DOI: 10.1111/cup.14099] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Kashetsky N, Mukovozov IM, Bergman J. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review. J Cutan Med Surg 2021;:12034754211004575. [PMID: 33849305 DOI: 10.1177/12034754211004575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jindal R, Chauhan P, Goyal D, Shirazi N. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature. Dermatol Ther 2021;34:e14951. [PMID: 33740317 DOI: 10.1111/dth.14951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Neri I, Conti F, Virdi A, Guglielmo A, Leonardi L, Corsini I, Ghizzi C, Gabrielli L, Lazzarotto T, Lanari M, Patrizi A, Misciali C. Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals. J Eur Acad Dermatol Venereol 2021;35:e357-9. [PMID: 33651419 DOI: 10.1111/jdv.17194] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Baeck M, Herman A. Chilblains and COVID-19: can recent epidemiological data shed light on the aetiological debate? Clin Exp Dermatol 2021;46:759-62. [PMID: 33522016 DOI: 10.1111/ced.14586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Larenas-Linnemann D, Luna-Pech J, Navarrete-Rodríguez EM, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Rio-Navarro BE, Estrada-Cardona A, Onuma-Takane E, Pozo-Beltrán CF, Valencia-Herrera AM, Ortiz-Aldana FI, Toledo-Bahena ME. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group. Curr Allergy Asthma Rep 2021;21:13. [PMID: 33630167 DOI: 10.1007/s11882-020-00986-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Cappel MA, Cappel JA, Wetter DA. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. Mayo Clin Proc 2021;96:989-1005. [PMID: 33714595 DOI: 10.1016/j.mayocp.2021.01.009] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
16 Koschitzky M, Oyola RR, Lee-Wong M, Abittan B, Silverberg N. Pediatric COVID toes and fingers. Clin Dermatol 2021;39:84-91. [PMID: 33972057 DOI: 10.1016/j.clindermatol.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatol Ther 2021;34:e14554. [PMID: 33210417 DOI: 10.1111/dth.14554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis 2021;102:53-5. [PMID: 33075530 DOI: 10.1016/j.ijid.2020.10.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
19 Baeck M, Peeters C, Herman A. Chilblains and COVID-19: further evidence against a causal association. J Eur Acad Dermatol Venereol 2021;35:e2-3. [PMID: 32866323 DOI: 10.1111/jdv.16901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Balestri R, Magnano M, Rizzoli L, Rech G. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature. Dermatol Ther 2020;33:e14229. [PMID: 32844512 DOI: 10.1111/dth.14229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Neri I, Patrizi A, Gabrielli L, Virdi A, Veronesi G, Corsini I, Lazzarotto T, Lanari M, Misciali C, Guglielmo A. Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles. J Eur Acad Dermatol Venereol 2020;34:e783-5. [PMID: 32815180 DOI: 10.1111/jdv.16881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]